Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
Condition(s):Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)Last Updated:December 11, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)Last Updated:December 11, 2020Terminated
Condition(s):Breast CancerLast Updated:December 4, 2020Completed
Condition(s):Breast Ductal Carcinoma in SituLast Updated:August 6, 2019Recruiting
Condition(s):Ductal Carcinoma In SituLast Updated:September 23, 2020Completed
Condition(s):Carcinoma in Situ; Bladder CancerLast Updated:June 12, 2015Completed
Condition(s):Ductal Breast Carcinoma in Situ; Estrogen Receptor-positive Breast CancerLast Updated:July 21, 2015Completed
Condition(s):Carcinoma in Situ of Bladder; Bladder CancerLast Updated:July 29, 2022Terminated
Condition(s):Breast CancerLast Updated:February 25, 2013Terminated
Condition(s):Breast Ductal Carcinoma In SituLast Updated:February 15, 2024Active, not recruiting
Condition(s):Ductal Carcinoma In Situ; Breast CancerLast Updated:August 31, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.